Global Computational Biology Market is valued at approximately USD 6.57 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 19.50% over the forecast period 2023-2030. Computational Biology is an interdisciplinary field that combines computational science and biological research to gain a deeper understanding of biological systems and solve biological problems using computational techniques and tools. It involves the application of mathematical modeling, statistical analysis, and computer algorithms to analyze and interpret biological data, simulate biological processes, and make predictions about biological systems. The Computational Biology market is expanding because of factors such as increasing bioinformatics research and an increasing number of clinical studies in pharmacogenomics and pharmacokinetics.
Bioinformatics and computational biology have undergone a lot of developments during the past 15 years, firmly establishing themselves as crucial components of modern biology. For instance, according to Department of Biotechnology (DBT) publications from February 2022, the demand for bioinformatics tools and knowledge has increased as a result of the expansion of sequence databases as a result of genome sequencing operations. According to the Alliance for Regenerative Medicine, Companies involved are working on cell and gene therapies raised around USD 23.1 billion in funding globally in 2021, an increase of about 16% from the USD 19.9 billion total year 2020.These, rising investments have led to a rise in the demand and adoption of bioinformatics biology, resulting in market growth. In addition, the growth of drug designing and disease modelling and growing R&D for drug discovery is creating a lucrative opportunity for the market. However, the high cost of computational biology stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Computational Biology Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, rising investment in drug discovery and research and development activities. Asia Pacific is expected to grow at a fastest rate during the forecast period, owing to factors such as an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
- Nimbus Discovery LLC
- Insilico Biotechnology AG
- Compugen Ltd.
- Simulation Plus Inc
- Chemical Computing Group
- Rhenovia Pharma SAS
- Dassault Systemes SE
- Genedata AG
- Rosa & Co. LLC
- Strand Life Sciences
Recent Developments in the Market:
- In May 2021 update, the World Health Organization (WHO) and the Swiss Confederation signed a Memorandum of Understanding (MoU) to start the first WHO BioHub Facility as a part of the WHO BioHub System. The facility, located in Spiez, Switzerland, acts as a hub for the secure receipt, sequencing, storage, and preparation of biological samples for transfer to other laboratories, and it also supports worldwide pathogen preparedness and informs risk assessments.
- In April 2021, Peptilogics, announced the completion of its Phase I clinical trial for its lead compound PLG0206, a potent, broad-spectrum anti-infective that has been given the United States Food and Drug Administration Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections (PJI).
Global Computational Biology Market Report Scope:
- Historical Data: 2020 - 2021
- Base Year for Estimation: 2022
- Forecast period: 2023-2030
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Application, Services, End Use, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
- Cellular & Biological Simulation
- Drug Discovery & Disease Modelling
- Preclinical Drug Development
- Clinical Trials
- Human Body Simulation Software
By Services:
By End Use:
- Academics & Research
- Commercial
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Computational Biology Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Computational Biology Market, by Application, 2020-2030 (USD Billion)
- 1.2.3. Computational Biology Market, by Services, 2020-2030 (USD Billion)
- 1.2.4. Computational Biology Market, by End Use, 2020-2030 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Computational Biology Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Computational Biology Market Dynamics
- 3.1. Computational Biology Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing bioinformatics research
- 3.1.1.2. Increasing number of clinical studies in pharmacogenomics and pharmacokinetics
- 3.1.2. Market Challenges
- 3.1.2.1. High Cost of Computational Biology
- 3.1.3. Market Opportunities
- 3.1.3.1. Growth of drug designing and disease modelling
- 3.1.3.2. Growing R&D for drug discovery
Chapter 4. Global Computational Biology Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Computational Biology Market, by Application
- 5.1. Market Snapshot
- 5.2. Global Computational Biology Market by Application, Performance - Potential Analysis
- 5.3. Global Computational Biology Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
- 5.4. Computational Biology Market, Sub Segment Analysis
- 5.4.1. Cellular & Biological Simulation
- 5.4.2. Drug Discovery & Disease Modelling
- 5.4.3. Preclinical Drug Development
- 5.4.4. Clinical Trials
- 5.4.5. Human Body Simulation Software
Chapter 6. Global Computational Biology Market, by Services
- 6.1. Market Snapshot
- 6.2. Global Computational Biology Market by Services, Performance - Potential Analysis
- 6.3. Global Computational Biology Market Estimates & Forecasts by Services 2020-2030 (USD Billion)
- 6.4. Computational Biology Market, Sub Segment Analysis
- 6.4.1. Contract
- 6.4.2. In-house
Chapter 7. Global Computational Biology Market, by End Use
- 7.1. Market Snapshot
- 7.2. Global Computational Biology Market by End Use, Performance - Potential Analysis
- 7.3. Global Computational Biology Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
- 7.4. Computational Biology Market, Sub Segment Analysis
- 7.4.1. Academics & Research
- 7.4.2. Commercial
Chapter 8. Global Computational Biology Market, Regional Analysis
- 8.1. Top Leading Countries
- 8.2. Top Emerging Countries
- 8.3. Computational Biology Market, Regional Market Snapshot
- 8.4. North America Computational Biology Market
- 8.4.1. U.S. Computational Biology Market
- 8.4.1.1. Application breakdown estimates & forecasts, 2020-2030
- 8.4.1.2. Services breakdown estimates & forecasts, 2020-2030
- 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Computational Biology Market
- 8.5. Europe Computational Biology Market Snapshot
- 8.5.1. U.K. Computational Biology Market
- 8.5.2. Germany Computational Biology Market
- 8.5.3. France Computational Biology Market
- 8.5.4. Spain Computational Biology Market
- 8.5.5. Italy Computational Biology Market
- 8.5.6. Rest of Europe Computational Biology Market
- 8.6. Asia-Pacific Computational Biology Market Snapshot
- 8.6.1. China Computational Biology Market
- 8.6.2. India Computational Biology Market
- 8.6.3. Japan Computational Biology Market
- 8.6.4. Australia Computational Biology Market
- 8.6.5. South Korea Computational Biology Market
- 8.6.6. Rest of Asia Pacific Computational Biology Market
- 8.7. Latin America Computational Biology Market Snapshot
- 8.7.1. Brazil Computational Biology Market
- 8.7.2. Mexico Computational Biology Market
- 8.8. Middle East & Africa Computational Biology Market
- 8.8.1. Saudi Arabia Computational Biology Market
- 8.8.2. South Africa Computational Biology Market
- 8.8.3. Rest of Middle East & Africa Computational Biology Market
Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Nimbus Discovery LLC
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Recent Developments
- 9.3.2. Insilico Biotechnology AG
- 9.3.3. Compugen Ltd.
- 9.3.4. Simulation Plus Inc
- 9.3.5. Chemical Computing Group
- 9.3.6. Rhenovia Pharma SAS
- 9.3.7. Dassault Systemes SE
- 9.3.8. Genedata AG
- 9.3.9. Rosa & Co. LLC
- 9.3.10. Strand Life Sciences
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption